Application 220326
- Type
- ANDA
- Sponsor
- APPCO PHARMA LLC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 002 | VILOXAZINE HYDROCHLORIDE | VILOXAZINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE | 200MG | No | No |
| 003 | VILOXAZINE HYDROCHLORIDE | VILOXAZINE HYDROCHLORIDE | CAPSULE, EXTENDED RELEASE | 150MG | No | No |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.